These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1977278)

  • 1. Somatostatin and its physiological significance in regulating the episodic secretion of growth hormone in the rat.
    Robinson IC; Jeffery S; Clark RG
    Acta Paediatr Scand Suppl; 1990; 367():87-92. PubMed ID: 1977278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The episodic secretory pattern of growth hormone regulates liver carbonic anhydrase III. Studies in normal and mutant growth-hormone-deficient dwarf rats.
    Jeffery S; Carter ND; Clark RG; Robinson IC
    Biochem J; 1990 Feb; 266(1):69-74. PubMed ID: 1968744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
    Massoud AF; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome.
    Leal-Cerro A; Soto A; Martínez MA; Alvarez P; Isidro L; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):745-9. PubMed ID: 12460324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide.
    Rigamonti AE; Cavallera G; Bonomo S; Deghenghi R; Locatelli V; Cella SG; Müller EE
    Eur J Endocrinol; 2001 Nov; 145(5):635-44. PubMed ID: 11720883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical growth-promoting effects induced by patterned infusions of somatostatin in female rats.
    Clark RG; Robinson IC
    Endocrinology; 1988 Jun; 122(6):2675-82. PubMed ID: 2897285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals.
    Achermann JC; Hindmarsh PC; Robinson IC; Matthews DR; Brook CG
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):575-85. PubMed ID: 10594518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement.
    Wehrenberg WB; Wiviott SD; Voltz DM; Giustina A
    Endocrinology; 1992 Mar; 130(3):1445-50. PubMed ID: 1347008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
    Rigamonti AE; Bonomo SM; Cella SG; Müller EE
    J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine.
    Rigamonti AE; Marazzi N; Cella SG; Cattaneo L; Müller EE
    J Endocrinol; 1998 Feb; 156(2):341-8. PubMed ID: 9518881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rebound release of growth hormone (GH) following somatostatin infusion in rats involves hypothalamic GH-releasing factor release.
    Clark RG; Carlsson LM; Rafferty B; Robinson IC
    J Endocrinol; 1988 Dec; 119(3):397-404. PubMed ID: 2906083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) secretion in the conscious rat: negative feedback of GH on its own release.
    Clark RG; Carlsson LM; Robinson IC
    J Endocrinol; 1988 Nov; 119(2):201-9. PubMed ID: 2904475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin withdrawal as generator of pulsatile GH release in the dog: a possible tool to evaluate the endogenous GHRH tone?
    Cella SG; Luceri M; Cattaneo L; Torsello A; Müller EE
    Neuroendocrinology; 1996 Jun; 63(6):481-8. PubMed ID: 8793889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of changing somatostatin tone on the pituitary growth hormone and thyroid-stimulating hormone responses to their respective releasing factor stimuli.
    Spoudeas HA; Matthews DR; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 1992 Aug; 75(2):453-8. PubMed ID: 1353504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravenous or intracerebroventricular injections of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on GH release in conscious, freely moving male rats.
    Yagi H; Kaji H; Sato M; Okimura Y; Chihara K
    Neuroendocrinology; 1996 Feb; 63(2):198-206. PubMed ID: 9053785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic mediation of reduced GH secretion in diabetic rats: evidence for reduced cholinergic inhibition of somatostatin release.
    Ismail I; Lewis M; Peters JR; Scanlon MF
    J Neuroendocrinol; 1995 Apr; 7(4):311-8. PubMed ID: 7647774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa.
    Gianotti L; Rolla M; Arvat E; Belliti D; Valetto MR; Ferdeghini M; Ghigo E; Müller EE
    Biol Psychiatry; 1999 Feb; 45(3):334-9. PubMed ID: 10023511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) secretion in the dwarf rat: release, clearance and responsiveness to GH-releasing factor and somatostatin.
    Carmignac DF; Robinson IC
    J Endocrinol; 1990 Oct; 127(1):69-75. PubMed ID: 1983310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
    García-Tornadú I; Rubinstein M; Gaylinn BD; Hill D; Arany E; Low MJ; Díaz-Torga G; Becu-Villalobos D
    J Endocrinol; 2006 Sep; 190(3):611-9. PubMed ID: 17003262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.